FRENCH pharmaceutical manufacturer Sanofi has struck a deal with leading Brazilian research institute, Fiocruz Public Health Center, to hasten development of a Zika vaccine.
In Jul the company had linked with a US Army research institute, to access one of the furthest advanced vaccines in development, and now all three organisations will collaborate to speed the outcome, the company said.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Oct 16
